Market research

Over the past several years, the market for SIBO diagnostics has been continuously expanding due to the increasing awareness of gastrointestinal diseases and diagnostic technology. SIBO is increasingly diagnosed when the small intestine has an excessive amount of bacteria causing bloating, diarrhea, stomach cramps, and increased  hydrogen levels. In other words, the higher the number of patients with this condition, the more imperative the requirement for accurate, non-invasive testing procedures such as breath tests. The SIBO diagnostics market size would grow at a CAGR of 4.8% from 2023 to 2031. It will reach US$ 266.81 million by 2031 from US$ 155.60 million in 2023. SIBO Diagnostics: An Overview Small Intestinal Bacterial Overgrowth or SIBO is an under-recognized condition that significantly affects the gut. The autoimmune condition results from a debalance in the number of bacteria in the small intestine, usually a result of poor mobility or anatomy. SIBO will cause bloating...